These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23582719)

  • 21. Sugar coating: bacterial protein glycosylation and host-microbe interactions.
    Tan FY; Tang CM; Exley RM
    Trends Biochem Sci; 2015 Jul; 40(7):342-50. PubMed ID: 25936979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New discoveries in bacterial N-glycosylation to expand the synthetic biology toolbox.
    Nothaft H; Szymanski CM
    Curr Opin Chem Biol; 2019 Dec; 53():16-24. PubMed ID: 31288139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical deamidation: a common pitfall in large-scale N-linked glycoproteomic mass spectrometry-based analyses.
    Palmisano G; Melo-Braga MN; Engholm-Keller K; Parker BL; Larsen MR
    J Proteome Res; 2012 Mar; 11(3):1949-57. PubMed ID: 22256963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of genes involved in the biosynthesis and attachment of Methanococcus voltae N-linked glycans: insight into N-linked glycosylation pathways in Archaea.
    Chaban B; Voisin S; Kelly J; Logan SM; Jarrell KF
    Mol Microbiol; 2006 Jul; 61(1):259-68. PubMed ID: 16824110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometry-based glycomics strategy for exploring N-linked glycosylation in eukaryotes and bacteria.
    Liu X; McNally DJ; Nothaft H; Szymanski CM; Brisson JR; Li J
    Anal Chem; 2006 Sep; 78(17):6081-7. PubMed ID: 16944887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding protein glycosylation pathways in bacteria.
    Li H; Debowski AW; Liao T; Tang H; Nilsson HO; Marshall BJ; Stubbs KA; Benghezal M
    Future Microbiol; 2017 Jan; 12():59-72. PubMed ID: 27689684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosynthesis of the N-linked glycan in Campylobacter jejuni and addition onto protein through block transfer.
    Kelly J; Jarrell H; Millar L; Tessier L; Fiori LM; Lau PC; Allan B; Szymanski CM
    J Bacteriol; 2006 Apr; 188(7):2427-34. PubMed ID: 16547029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GlycoSNAP: A High-Throughput Screening Methodology for Engineering Designer Glycosylation Enzymes.
    Ollis AA; Chai Y; DeLisa MP
    Methods Mol Biol; 2015; 1321():37-47. PubMed ID: 26082213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial Glycoengineering as a Biosynthetic Route to Customized Glycomolecules.
    Yates LE; Mills DC; DeLisa MP
    Adv Biochem Eng Biotechnol; 2021; 175():167-200. PubMed ID: 30099598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial glycoengineering: Cell-based and cell-free routes for producing biopharmaceuticals with customized glycosylation.
    Palma JA; Bunyatov MI; Hulbert SW; Jewett MC; DeLisa MP
    Curr Opin Chem Biol; 2024 Aug; 81():102500. PubMed ID: 38991462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the bacterial glycocode: recent advances in bacterial glycoproteomics.
    Longwell SA; Dube DH
    Curr Opin Chem Biol; 2013 Feb; 17(1):41-8. PubMed ID: 23276734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial protein N-glycosylation: new perspectives and applications.
    Nothaft H; Szymanski CM
    J Biol Chem; 2013 Mar; 288(10):6912-20. PubMed ID: 23329827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging facets of prokaryotic glycosylation.
    Schäffer C; Messner P
    FEMS Microbiol Rev; 2017 Jan; 41(1):49-91. PubMed ID: 27566466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL.
    van Sorge NM; Bleumink NM; van Vliet SJ; Saeland E; van der Pol WL; van Kooyk Y; van Putten JP
    Cell Microbiol; 2009 Dec; 11(12):1768-81. PubMed ID: 19681908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
    Strasser R
    Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.
    Pratama F; Linton D; Dixon N
    Microb Cell Fact; 2021 Oct; 20(1):198. PubMed ID: 34649588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose.
    Bobrowicz P; Davidson RC; Li H; Potgieter TI; Nett JH; Hamilton SR; Stadheim TA; Miele RG; Bobrowicz B; Mitchell T; Rausch S; Renfer E; Wildt S
    Glycobiology; 2004 Sep; 14(9):757-66. PubMed ID: 15190003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological significance of glycosylation in therapeutic proteins.
    Li H; d'Anjou M
    Curr Opin Biotechnol; 2009 Dec; 20(6):678-84. PubMed ID: 19892545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein glycosylation in bacteria: sweeter than ever.
    Nothaft H; Szymanski CM
    Nat Rev Microbiol; 2010 Nov; 8(11):765-78. PubMed ID: 20948550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein glycosylation in Archaea: sweet and extreme.
    Calo D; Kaminski L; Eichler J
    Glycobiology; 2010 Sep; 20(9):1065-76. PubMed ID: 20371512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.